MOLECULAR CELLULAR BIOLOGY, 2008, p. 3446â€“3456                                                                            Vol. 28,  10
0270-7306/08/$08.00â«¹0 doi:10.1128/MCB.02246-07
Copyright Â© 2008, American Society Microbiology. Rights Reserved.



      p23/Sba1p Protects Hsp90 Inhibitors Independently                       Intrinsic Chaperone ActivityäŒ¤â€¡
                      Fedor Forafonov,1 Oyetunji  Toogun,2â€  Iwona Grad,1 Elena Suslova,1
                                    Brian C. Freeman,2 Didier Picard1* partement Biologie Cellulaire, UniversiteÂ´ Gene`ve, Sciences III, 30 Quai Ernest-Ansermet, CH-1211 Gene`ve 4, Switzerland,1
                Department Cell Developmental Biology, University Illinois, Urbana, Illinois 618012
                      Received 19 December 2007/Returned modification 30 January 2008/Accepted 11 March 2008

             molecular chaperone Hsp90 assists subset cellular proteins essential eukaryotes. cohort
          cochaperones contributes regulates multicomponent Hsp90 machine. Unlike biochemical
          activities cochaperone p23, vivo functions structure-function relationship remain poorly
          understood, genetically tractable model organism Saccharomyces cerevisiae. SBA1 gene           encodes p23 ortholog species essential gene. absence p23/Sba1p,
          yeast mammalian cells hypersensitive Hsp90 inhibitors. protective function Sba1p depends
          abilities bind Hsp90 block Hsp90 ATPase inhibitor binding. contrast, protective
          function Sba1p does require Hsp90-independent molecular chaperone activity Sba1p.           structure-function analysis suggests Sba1p undergoes considerable structural rearrangements           binding Hsp90 large size p23/Sba1p-Hsp90 interaction surface facilitates maintenance           high affinity despite sequence divergence evolution. large interface contribute preserv-
          ing protective function environment Hsp90 inhibitory compounds produced various
          microorganisms.


   Sba1p ortholog (4, 15) Hsp90 cochaperone p23,                  conformation lid ATP binding pocket small acidic eukaryote-specific protein, budding yeast                 closed conformation, providing explanation stabiliz-
Saccharomyces cerevisiae (reviewed references 16 46).                    ing effects Sba1p (2). molecular chaperone Hsp90 highly conserved                            Despite regulatory interactions p23/Sba1p abundant cytosolic nuclear protein required                     Hsp90, Hsp90 absolutely essential viability. Deletion
folding, assembly, maintenance subset proteins (23,                 mutants p23 orthologs budding fission yeasts 44â€“46, 62). activity N-terminal ATPase domain                     viable (4, 15, 38). Similarly, p23-null mice initially develop
regulated cochaperones. biochemical                     relatively normally dying birth retarded
function ATP hydrolysis Hsp90 substrates                    lung development (22). Overall, vivo functions p23/
stood, genetic experiments budding yeast unambiguously                       Sba1p remain poorly understood. S. cerevisiae, early 
demonstrated important                        ports role SBA1 â€œgeneral control responseâ€? substrates essential viability (42). p23 binds                 amino acid starvation (14) maintaining chromosome
ATP-bound conformation molecular chaperone                               stability (39) investigated. 
Hsp90, inhibits ATP hydrolysis,  result stabilizing                 ported defects âŒ¬sba1 cells relate functions verte- ATP-bound state, prolongs interaction                           brate substrates Hsp90 assayed heterologous envi-
Hsp90 substrates (11, 24, 26, 32, 33, 50â€“52,                    ronment (4, 7, 8, 13, 15, 17, 20, 28, 40).  56, 58, 60). effects Hsp90 inhibitors geldana-                   gene SBA1 (sensitivity benzoquinone ansamycins)
mycin (GA) radicicol, compete ATP                            derives fact mammalian steroid receptors binding, compounded interfering binding                      sensitive inhibition Hsp90 inhibitors chem-
p23/Sba1p (15, 26). recently reported crystal struc-                   ical class tested âŒ¬sba1 strain, genuine yeast
ture Sba1p-Hsp90 complex shows intimate contacts                      functions proliferation examined initial
volving multiple regions Sba1p N-terminal                   report (4). essential role Sba1p maintaining telomeres
middle domains Hsp90. complex, consists                      promoting dynamic interactions telomerase Sba1p monomers Hsp90 dimer, Sba1p favors Hsp90                       telomeric repeats recently recognized
                                                                                (59). explain previously reported chromosome
                                                                                instability cells overexpressing Sba1p.     * Corresponding author. Mailing address: partement Biologie            understood Sba1p requirement, manifested im-
Cellulaire, UniversiteÂ´ Gene`ve, Sciences III, CH-1211 Gene`ve 4,            mediately following deletion SBA1 gene, Switzerland. Phone: 41 22 379 6813. Fax: 41 22 379 6928. E-mail:                compensated seemingly long-term estab-
didier.picard@cellbio.unige.ch.                                                 lishment âŒ¬sba1 strains.
   â€  Passed away 3 August 2007.
   â€¡ Supplemental material article http://mcb
                                                                                    role Sba1p yeast biology itself .asm.org/.                                                                      contributions different Sba1p domains functions remain
   äŒ¤
     Published ahead print 24 March 2008.                                 poorly understood. example, relevance Hsp90-

                                                                         3446
 VOL. 28, 2008                                                                                    p23 PROTECTS Hsp90 INHIBITORS                                3447


independent molecular chaperone function,                               4 12  NuPAGE gels (Invitrogen) morpholineethanesulfonic acid (MES)
described human p23 (5, 19, 61), remains unclear.                           buffer analyzed immunoblotting mouse monoclonal anti-
                                                                                       Flag M2 antibody (Sigma) chicken polyclonal antibody preparation
contribute maturation specific Hsp90 substrates (40),                        raised yeast Hsp82p (30). importance endogenous yeast processes                                 Production purification recombinant proteins. wild-type point addressed. set identify new phe-                            mutant Sba1p proteins expressed tag Rosetta (Novagen)
notype S. cerevisiae strains lacking Sba1p character-                       bacteria using pET expression constructs. proteins purified essentially
                                                                                       described human p23 (19). Briefly, crude clarified protein extracts ize role Hsp90 regulation Sba1p chaperone activity
                                                                                       resolved DEAE FF resin (GE Healthcare) using linear gradient 200 phenotype.                                                                    650 mM NaCl. appropriate fractions pooled, diluted threefold                                                                                        TEN0.0 buffer (10 mM Tris-HCl [pH 6.9], 1.0 mM EDTA, 1.0 mM phenylmeth-
                                                                                       ylsulfonyl fluoride [PMSF], 1.0 â?®g/ml pepstatin, 1.0 â?®g/ml leupeptin, 0.25 â?®M
                         MATERIALS METHODS                                         aprotinin), resolved ResourceQ resin (GE Healthcare) linear
   Yeast strains. strain BY4742 (MATâ?£ his3âŒ¬1 leu2âŒ¬0 lys2âŒ¬0 ura3âŒ¬0) (6)             gradient 100 400 mM NaCl. appropriate fractions pooled, used wild-type strain. strain, âŒ¬sba1 (MATâ?£ his3âŒ¬1 leu2âŒ¬0       total volume reduced â¬ƒ200 â?®l using microconcentrator device lys2âŒ¬0 ura3âŒ¬0 sba1âŒ¬::kanMX4), âŒ¬hsc82, âŒ¬hsp82 derivatives obtained             10-kDa cutoff (Amicon Ultrafree-4; Millipore), resolved Superdex- Research Genetics used generate âŒ¬pdr5 derivatives BYP1                 200 gel filtration column (GE Healthcare) equilibrated TEN0.1 buffer (10 mM
(BY4742 pdr5âŒ¬::HIS3) BYP2 (BY4742 pdr5âŒ¬::HIS3 sba1âŒ¬::kanMX4),                   Tris-HCl [pH 6.9], 1.0 mM EDTA, 100 mM NaCl).
spectively. produce PCR product substitute HIS3 coding region             N-terminal polyhistidine-tagged Hsp82p fusion protein expressed PDR5 gene homologous recombination, HIS3 sequences                 Rosetta (Novagen) bacteria using pET expression construct (pET-His6HSP82),
amplified plasmid pRS313 using primers 5â¬˜-agacccttttaagttttcgtatc         kind gift J. Buchner (Technische UniversitaÂ¨t, Garching, Ger-
cgctcgttcgaaagactttagacaaaaatgACAGAGCAGAAAGCCCT-3â¬˜ 5â¬˜-tctttcgga                    . purify protein near homogeneity, crude clarified protein
cattgaactttgatttatcagagctggtaaaACTCAACCCTATCTCGGTCT-3â¬˜. lower-                     extract batch adsorbed Talon metal affinity resin (Clontech). resin
case letters represent flanking sequences PDR5 open reading frame,              washed 1â«» Talon binding/wash buffer (50 mM sodium phosphate [pH
including ATG (boldface) 5â¬˜ nucleotides â«¹4686 â«¹4725             7.0], 300 mM NaCl, 10  glycerol, 1.0 mM PMSF, 1.0 â?®g/ml pepstatin, 1.0 â?®g/ml
located 160 bp 3â¬˜ stop codon. Uppercase letters correspond             leupeptin, 0.25 â?®M aprotinin), adsorbed protein eluted 1â«» Talon
sequences matching beginning HIS3 open reading frame se-                elution buffer (50 mM sodium phosphate [pH 7.0], 150 mM imidazole, 300 mM
quences downstream plasmid pRS313.                                            NaCl, 10  glycerol, 1.0 mM PMSF, 1.0 â?®g/ml pepstatin, 1.0 â?®g/ml leupeptin,
   Plasmids. Wild-type Sba1p truncation point mutants ex-             0.25 â?®M aprotinin). indicated Sba1p, eluted sample diluted
pressed yeast Flag-tagged derivatives plasmid pYES/Flag (1).           threefold TEN0.0 buffer, resolved ResourceQ resin, concentrated, plasmid URA3-marked 2â?®m episome galactose-inducible promoter             Superdex-200 gel filtration column TEN0.1 buffer protease
GAL1. SBA1 sequences generated PCR inserted BamHI                  inhibitors. EcoRI sites pYES/Flag. introduction single point mutations              Protein-refolding assay. protein-refolding assays performed  deletion codons 102 113, SBA1 sequences cloned               scribed previously (18). Briefly, firefly luciferase (Sigma) prepared 4
BluescriptM13â«¹ mutagenized QuikChange site-directed mutagenesis             mg/ml glycylglycine (pH 7.4) denatured 37Â°C 30 min dilution
method (Stratagene) directed manufacturer.                                   unfolding buffer (25 mM HEPES [pH 7.5], 50 mM KCl, 5.0 mM MgCl2, 5.0
   Growth assays. growth assays, strains precultured minimal selec-        mM mercaptoethanol, 6 M guanidinium-HCl). molecular chaperone
tive medium 2  glucose. Cultures washed diluted               activity assays, 1.0-â?®l aliquot (312.5 ng) denatured luciferase solution optical density 600 nm 0.1 serially diluted times. microliters     added 124 â?®l refolding buffer (25 mM HEPES [pH 7.5], 50 mM KCl, 5.0 dilution spotted row plates minimal selective medium          mM MgCl2, 10 mM DTT, 1.0 mM ATP) supplemented 3.2 â?®M
containing 2  galactose. Plates supplemented radicicol GA 10         bovine serum albumin (BSA) wild-type point mutant Sba1p. reactions
mM stocks ethanol dimethyl sulfoxide (DMSO), respectively,              incubated 30 min 37Â°C. Refolding triggered addition solvent  Images acquired growth 5 days 30Â°C.                   Hsp70 Hdj1 1.6 â?®M 3.2 â?®M, respectively, allowed proceed    Preparation yeast extracts. Flag-tagged variants Sba1p ex-           2 h. Aliquots (1.0 â?®l) removed indicated time points mixed pressed strain BYP2. Transformants precultured overnight selective          49 â?®l Bright-Glo luciferase assay reagent (Promega), luciferase activity
minimal medium 2  glucose, washed water, incubated             determined using Ultra Evolution plate reader (Tecan). percent 6 h yeast extract-peptone (YEP) 2  galactose. Cell pellets 150 â?®l       luciferase activity calculated using equivalent native luciferase resuspended volume lysis buffer (20 mM Tris-HCl [pH 8.0],          diluted extent refolding buffer supplemented 3.2 â?®M BSA.
1 mM EDTA, 100 mM NaCl, 20 mM Na2MoO4, 20  glycerol) containing yeast                   ATPase assay. ATPase activity Hsp82p measured using Enz-
protease inhibitor cocktail recommended supplier (Sigma). Cells         Chek phosphate assay kit (Molecular Probes) previously described (9, 52).
mechanically broken Mini-BeadBeater (BioSpec Products) using 500 â?®l          Briefly, 1 â?®M Hsp82p monomer supplemented indicated
0.5-mm zirconia-silica beads. cell lysis, tubes placed precooled         levels Sba1p point mutants 1 mM ATP presence Mini-BeadBeater aluminum rack violently shaken 5 min 4Â°C.               absence 60 â?®M radicicol buffer C (40 mM HEPES [pH 7.5], 150 mM KCl,
crude extracts cleared centrifugation 45,000 rpm 30 min 4Â°C,         5 mM MgCl2, 2 mM DTT) total volume 150 â?®l. reactions protein concentrations adjusted 1, 3, 5 mg/ml lysis buffer    incubated 37Â°C 90 min diluted fivefold 100-â?®l phosphate experiments Fig. 2B 3, 2C, 6, respectively.                             assay manufacturerâ€™s instructions. standard curve generated
   IP immunoblotting experiments. Flag-tagged proteins immuno-             using inorganic phosphate solution provided manufacturer. radi-
precipitated crude yeast extracts follows. milligram (experiments       cicol control samples serve confirm phosphate release Hsp90 dependent
Fig. 2B 3) 5 mg protein extracts supplemented ATP 10 mM           course, Sba1p itself displays ATPase activity  Triton X-100 0.2  incubated 20 â?®l packed EZview red                    Limited proteolytic digestion. Limited proteolytic digestion Sba1p pro-
anti-Flag M2 affinity gel (Sigma) 3 h 4Â°C. resin collected          teins accomplished incubating (10 â?®g  50 ng trypsin washed times buffer (lysis buffer protease inhibitors,         TEN0.1 buffer (10 mM Tris-HCl [pH 6.9], 1.0 mM EDTA, 100 mM NaCl).
ATP, Triton X-100) unless indicated  Wash steps included change          Aliquots removed 0 15 min resolved sodium dodecyl tubes ensure removal Hsp90 nonspecifically bound         sulfate-polyacrylamide gel electrophoresis, products visualized plastic wall. resin-bound immunoprecipitates incubated 1â«» LDS            Coomassie blue staining.
protein sample buffer (Invitrogen) 10 min 50Â°C eluted protein               GA binding assay. Increasing levels recombinant Hsp82p (1 1,000 nM)
supernatants adjusted 100 mM dithiothreitol (DTT) boiled 10            incubated indicated Sba1p protein (16 â?®M) 12.5 â?®l
min. coimmunoprecipitation  IP) experiment testing release           binding buffer (40 mM HEPES-KOH [pH 7.5], 150 mM KCl, 5.0 mM MgCl2,
Hsp90 presence radicicol follows. resin-bound immu-          2.0 mM DTT, 200 â?®M ATP). chaperone reactions mixed 12.5
noprecipitates split parts wash: eluted   â?®l fluorescein isothiocyanate (FITC)-GA (InvivoGen) (8.0 nM FITC-GA, 40 processed mentioned  parts incubated IP         mM HEPES-KOH [pH 7.5], 150 mM KCl, 5.0 mM MgCl2) low-binding,
buffer containing 10 mM ATP 10 â?®M radicicol 4Â°C 20 min            black, 96 plate  Microplate; Molecular Devices) incubated washed times ATP. Protein samples resolved             4Â°C 120 min. anisotropy values determined using Ultra
 3448       FORAFONOV ET AL.                                                                                                            MOL. CELL. BIOL.




   FIG. 1. âŒ¬sba1 strains hypersensitive radicicol (Rd). Shown growth assay 10-fold serial dilutions cells isogenic
strains indicated genotypes.


Evolution plate reader (Tecan, ). apparent Hsp82 affinities GA absence presence Sba1p protein derivatives determined fitting curve data replicates according formula
m1 â«¹ m2 â«¹ m0 â«º å†‘å…±m1 â«¹ m2 â«¹ m0å…²2 â«º 4 â«» m2 â«» m0
                                                                   â«» m3                               2 â«» m2
m1 â«½ calculated dissociation constant (Kd); m2 â«½ total [FITC-GA]; m3 â«½ maximal change anisotropy, set experiment (59).
   Assays MEFs. isolation culture mouse embryo fibroblasts
(MEFs) wild type corresponding p23 gene disruption mouse line described (22). proliferation assays, cells seeded plates triplicates density 100,000 cells  20 
confluence). 12 h later, day 0, number cells verified CASY cell counter model TT 40 nM GA added. Cells counted 12 h
later (day 0.5) 24-h intervals. determine effects GA levels Raf-1, cells seeded 4 â«» 106 cells      FIG. 2. p23-negative MEFs hypersensitive GA.   Growth
plate 4 h prior treatment 60 nM GA. time intervals, cells     curves wild-type (WT) p23-null (â«º/â«º) cells cultured lysed mixture containing 10 mM Tris-HCl (pH 8.0), 137 mM NaCl, 2          40 nM GA (added day 0). (B) Ratios numbers treated
mM EDTA, 10  glycerol, 1  Triton X-100, protease inhibitors. Equal              untreated cells. Cell numbers experimental series amounts total protein analyzed immunoblotting anti-Raf-1         standardized experimentally determined values day 0 (set polyclonal antibody (C-12 Santa Cruz). filter probed     100 ). Error bars standard deviations  clarity monoclonal antibody ab8245 GAPDH (glyceraldehyde-3-phosphate             data points).
hydrogenase; Abcam), served loading control.


                                 RESULTS
                                                                                    relatively low dose GA, p23-null cells rapidly stopped
   novel âŒ¬sba1 phenotype. explore vivo functions                     growing died, wild-type p23 cells continued
Sba1p budding yeast S. cerevisiae, screened spe-                      grow 2 days survived longer (Fig. 2).
cific growth defects âŒ¬sba1 strain panel different                      Numerous studies published demonstrating growth media presence different drugs.                       Hsp90 inhibitors induce apoptosis wide variety different
defect observe simple assay                           cell types   example, references 10, 35, 62). hypersensitivity âŒ¬sba1 strain Hsp90 inhibitors                        likely MEFs died apoptosis, radicicol GA (Fig. 1A; Fig. 3D). High concentra-                       confirmed assumption directly. dramatic
tions radicicol inhibitory, albeit weakly, iso-                  difference effects GA wild-type versus p23-
genic wild-type strain, deletion PDR5 gene,                          null cells supports notion p23 fulfills protective role encodes membrane-associated drug export pump, fur-                          Hsp90 inhibitors mammalian cells.
ther accentuates hypersensitivity cells lack Sba1p.                     Sba1p interacts Hsp90 isoforms. S. cerevisiae ex-
yeast, radicicol consistently slightly potent                      presses Hsp90 isoforms, Hsp82p Hsc82p, needs GA (48; data shown). subsequent vivo ex-                         considered exploring phenotype âŒ¬sba1 cells. periments yeast, used âŒ¬pdr5 strain                          amino acid sequences isoforms 95  identical
increased radicicol sensitivity âŒ¬sba1 phenotype.                             (674 709 amino acids). half differences
   mammalian Sba1p ortholog p23 protects mammalian                              map evolutionarily poorly conserved dispensable
cells GA. view extensive conservation                         (30) charged domain N-terminal middle 
Hsp90 chaperone machine, wished assess generality                         mains, direct evidence literature Sba1p protective function p23/Sba1p newly identified                         interacts Hsc82p, exception reference yeast. Having previously generated p23-null mouse line (22),                      unpublished results (15).  decided verify ex- access wild-type p23-null MEFs. Cells                       perimentally Sba1p interacts isoforms.
seeded low density  20 ) allow vigorous                           Sba1p N-terminal Flag tag (Fig. 3A) expressed growth period days. absence GA,                         wild-type strain strains lacking p23-null cells grew slightly slowly wild-type cells                    Hsp90 isoform. IP experiment revealed Sba1p inter-
previously reported (31).  presence                     acts similarly Hsc82p Hsp82p (Fig. 3B).
 VOL. 28, 2008                                                                       p23 PROTECTS Hsp90 INHIBITORS                     3449




   FIG. 3. Hsp90 interaction vivo complementation length truncated forms Sba1p.   Schematic representation Sba1p
truncation mutants. N-terminal Flag tag removed residues indicated. p23/Sba1 signature motif underlined. (B) Sba1p interacts Hsp82p Hsc82p. immunoblot Hsp90 IP experiment shown. Flag-tagged Sba1p expressed isogenic strains
expressing Hsp90 isoforms used IP Hsp90 anti-Flag resin. immunoblot probed polyclonal Hsp90
antibodies recognizing isoforms  lanes labeled â€œinputâ€?; uppermost bands correspond length Hsp82p Hsc82p, lower bands degradation products). (C) Expression Hsp90 interaction Sba1p truncation mutants. Flag-tagged Sba1p derivatives shown panel expressed âŒ¬sba1 strain. Total extracts (40 â?®g  anti-Flag immunoprecipitates immunoblotted anti-Flag anti-Hsp90 antibodies indicated. case length Flag-Sba1b âŒ¬131â€“216 mutant, times immunoprecipitate loaded facilitate comparison poorly expressed mutants. (D) 130 N-terminal amino acids Sba1p sufficient conferring radicicol (Rd) resistance. growth assay fivefold serial dilutions âŒ¬sba1 âŒ¬pdr5 cells expressing Sba1p proteins indicated left performed increasing concentrations radicicol GA 30 37Â°C.



   N-terminal domain Sba1p sufficient Hsp90                   truncation mutants allow direct comparison binding complementation. investigate mode                     length Sba1 construct IP experiment, results
action Sba1p vivo, generated panel Sba1p trun-                suggest N-terminal truncation internal deletion
cation mutants analyzed Hsp90 binding                      mutants defective Hsp90 binding. growth
complementation radicicol hypersensitivity. wild-type               assay displayed Fig. 3D demonstrates N-terminal mutant proteins expressed N-terminal Flag                  130 amino acids Sba1 (sba1âŒ¬131â€“216) sufficient tag control galactose-inducible GAL1 pro-                  conferring radicicol resistance âŒ¬sba1 strain. evident
moter. Flag tag overexpression effect               normal temperature (30Â°C) mild heat stress complementation. Note toxic effects               (37Â°C), sensitizes cells Hsp90 inhibitors.  overexpression Sba1p growth strains used            N-terminal domain consistently complements better
study (data shown), despite previous report                 wild type presence Hsp90 inhibitors
working strains different genetic background                   radicicol GA.
slightly elevated temperatures (40). mutants shown                 Differential effects Sba1p point mutants Hsp90 bind- Fig. 3A, âŒ¬131â€“216 C-terminal truncation mutant               ing complementation. aforementioned truncation ex-
stably expressed. mutant lacks poorly conserved                periments suggested N-terminal 15 residues apparently unstructured, highly acidic tail, carry             signature motif WPRLTKEK important folding
contribute chaperone activity (60, 61). judged             activity Sba1p. decided mutate systematically IP experiment Fig. 3C, portion Sba1p comprising                Sba1p residues conserved patches N-ter- N-terminal 130 amino acids sufficient bind Hsp90.                 minal domain additional conserved ones just C observation agrees previous reports,                 terminal signature motif assess ability C-terminal tail human Sba1p ortholog p23                bind Hsp90 complement âŒ¬sba1 strain (Fig. 4). required chaperone activity Hsp90 binding (36,               proline residues regions altered 60, 61). Removal N-terminal 15 amino acids Sba1p               avoid major structural perturbations. contrast internal p23 signature motif WPRLTKEK severely                    truncation mutants, point mutants expressed similar
stabilizes protein. low levels                 levels compared wild-type Sba1p, exception  3450      FORAFONOV ET AL.                                                                                                 MOL. CELL. BIOL.


                                                                              mutants tested ability                                                                            complement âŒ¬sba1 strain, classes apparent
                                                                           (Fig. 4 Table S1 supplemental material).                                                                            unable bind Hsp90 high affinity (W12A                                                                            W104A) failed confer radicicol resistance. L107S                                                                            Y116A bind (albeit L107S binds somewhat                                                                             complement. A13S K113A, display                                                                            reduction Hsp90 binding, R106A, binds
                                                                           Hsp90 like wild type, appear complement slightly
                                                                           better wild type. complementing mutant                                                                            bind Hsp90  tentatively 
                                                                           cluded point Hsp90 binding necessary                                                                            sufficient protection radicicol.
                                                                              Correlating vitro vivo activities Sba1p mutants.
                                                                           attempt correlate biochemical vivo comple-
                                                                           mentation activities Sba1p point mutants, performed
                                                                           vitro assays recombinant proteins. selected set                                                                            mutants represent distinct classes mu-
                                                                           tants  Table S1 supplemental material). Wild-type
                                                                           mutant Sba1p proteins produced bacteria, purified
                                                                           homogeneity, analyzed known p23 family func-
                                                                           tions vitro chaperone activity inhibition Hsp82p
                                                                           ATPase. molecular chaperone capacities various
                                                                           Sba1 proteins determined utilizing established vitro
                                                                           assay. assesses ability test protein maintain
                                                                           chemically denatured firefly luciferase folding-competent
                                                                           state refolding molecular chaperone couple Hsp70-
                                                                           Hdj1 (18). Thirty percent total luciferase activity
                                                                           recovered presence wild-type Sba1p (Fig.
                                                                           5A). Note C-terminal truncation mutants Sba1p                                                                            completely defective function better BSA
                                                                           maintaining luciferase refolding (36, 60, 61; data    FIG. 4. Hsp90 interaction vivo complementation Sba1p
point mutants. wild-type Sba1p (WT) point mutants            shown) assay complete absence expressed Flag-tagged versions âŒ¬sba1 âŒ¬pdr5 strain.   Ex-       Hsp90. contrast, point mutants retain  albeit 
pression Hsp90 interaction Sba1p point mutants. immuno-         duced, chaperone activity fall general activity
blots represent different IP experiments. ATP present           classes: W12A, A13S, W104A, Y116A â¬ƒ60  incubation anti-Flag resin experiments, IP experiment 1 (IP1), ATP omitted buffer used      wild-type activity, R106A K113A retain wash immunoprecipitates. Note doublet observed        â¬ƒ32 . interesting alterations reduce
Flag-Sba1 experiments, presumably C-terminal            chaperone activity Sba1p despite fact map cleavage. weaker band Flag-Sba1 immuno-            predicted surface residues located outside acidic tail,
globulin light chain. details, Materials Methods                                                                            required chaperone activity.  reduced legend Fig. 3C. (B) Radicicol (Rd) sensitivity âŒ¬sba1 âŒ¬pdr5
strains expressing Sba1p point mutants. Growth assays         chaperone activities point mutants correlate described legend Fig. 3D.                                        vivo activities.
                                                                              experiments Fig. 4A indicated Sba1p
                                                                           point mutants reduced ability IP Hsp90 W104A, consistently slightly abundant (Fig. 4A)              crude extracts, albeit different degrees. relative inter-
(data shown). IP experiments performed ex-                  action affinities W12A, A13S, W104A, R106A, K113A
plore interaction Hsp90 cell extracts.            explored purified components monitoring
yeast  IP Hsp90 Sba1p observed             Sba1p-dependent inhibition ATPase activity presence ATP (15, 25; data shown).                Hsp82p. expected, wild-type Sba1p reduces
incubation anti-Flag resin, ATP present              ATP hydrolysis rate Hsp82p â¬ƒ50  (Fig. 5B), buffer favor assembly maintenance Sba1p-Hsp90                consistent stabilization ATP-bound form (9, 33,
complexes. Immunoprecipitates washed                      52, 56). Using observed ATPase rates Sba1p titration,
buffer ATP (Fig. 4A, upper panels labeled IP1)              calculated Sba1p-Hsp82p dissociation constant â¬ƒ2.2 ATP (lower panels labeled IP2). Sba1p mutants                  â?®M, good agreement prior report â¬ƒ1.8
(W12A W104A) severely defective Hsp90 binding.                  â?®M (56). point mutants, A13S, R106A, absence ATP washing, mutants                     K113A, functionally interact Hsp82p, albeit lower
(A13S K113A) lose Hsp90 quantitatively,                 affinities â¬ƒ33.1, 21.5, 4.2 â?®M, respectively (Fig. 5B). mutants (Q14A, R15A, R106A, L107S)                      contrast, W12A W104A apparently unable inhibit
intermediate retaining Hsp90.                                           ATPase activity Hsp82p (Fig. 5C). fact, increasing
 VOL. 28, 2008           p23 PROTECTS Hsp90 INHIBITORS                        3451


                concentrations mutants stimulated                 ATPase rate, suggesting alternative mode interaction
                effect Hsp82p.  ability bind                 regulate Hsp90 ATPase activity necessary comple-
                mentation âŒ¬sba1 phenotype. A13S, R106A,                 K113A mutants inhibit Hsp90 ATPase test tube
                protect high radicicol concentrations living cells.
                mutant Y116A, affinity slightly
                higher (1.1 â?®M) wild-type Sba1p, appears                 special case discussed  Importantly,
                Y116A results point binding inhibition                 ATPase sufficient vivo complementation.
                   point mutants W12A W104A structurally loos-
                ened. Unlike mutants, W12A W104A proved                 defective binding regulating Hsp90 confer-
                ring radicicol resistance cells, despite fact W12                 W104 appear recently published
                Sba1p-Hsp82p interface (2). order 
                standing differences classes mutants,
                global structures investigated limited proteolysis.
                light trypsin treatment, observed slight digestion                 wild-type Sba1p point mutants A13S, R106A,                 K113A appearance faster-migrating species (â¬ƒ25
                kDa) (Fig. 5D). contrast, W12A W104A                 completely digested small digestion products (â¬?5
                kDa) apparent.  W12A W104A mutants
                adopt distinct loosened conformations relative                 Sba1p mutants. loosened conformation,
                Hsp90 recognize substrates, albeit                 poor binding affinity, explain stimulatory effect
                ATPase. noteworthy W12A W104A                 clearly grossly misfolded accumulate appre-
                ciable levels Escherichia coli yeast retain
                chaperone activity. structural biochemical defects,
                 appear compromise ability complement
                âŒ¬sba1 cells.
                   Sba1p reduces GA binding Hsp90 vitro p23 pro-
                tects substrate vivo. appeared point study
                Sba1p protect Hsp90 inhibitors. Complex 
                mation intrinsic chaperone activity Sba1p ap-
                peared necessary, albeit sufficient, function.
                called direct test Sba1p prevents 


                   FIG. 5. vitro characterization biochemical activities Sba1p
                point mutants.   Sba1p point mutants retain molecular chaperone
                activity. bar graph shows recovered luciferase activities,                 indicative ability wild-type Sba1p (WT) point mutants
                maintain denatured firefly luciferase refoldable state refold-
                ing Hsp70 Hdj1. BSA used negative control. data
                represent average values independent experiments. (B
                C) Sba1p point mutants display differential effects ATP
                hydrolysis Hsp82p. ATPase activity expressed function                 Sba1p concentrations. data Sba1p mutants pre-
                sented separate graphs facilitate reading represent                 average values independent experiments. (D) Sba1p
                mutants inhibit ATPase Hsp82p distinct 
                formational states. structures Sba1p mutants probed using
                limited proteolytic digestion trypsin. digestion 0 (lanes
                marked â€œâ«ºâ€?) 15 min (lanes marked â€œâ«¹â€?), samples resolved
                sodium dodecyl sulfate-polyacrylamide gel electrophoresis vi-
                sualized Coomassie blue staining.
 3452     FORAFONOV ET AL.                                                                                                    MOL. CELL. BIOL.




                                                                           FIG. 7. Y116A-Hsp90 interaction insensitive radicicol
                                                                         (Rd). Shown immunoblots IP experiment antibodies                                                                          Flag-tagged wild-type (WT) mutant (Y116A) Sba1p expressed                                                                          âŒ¬sba1 yeast strain. fraction crude yeast extract loaded                                                                          â€œinput,â€? anti-Flag immunoprecipitate analyzed
                                                                         directly incubation indicated.



                                                                         Figure 8 shows endogenous Hsp90 substrate Raf-1
                                                                         (54) degraded rapidly given GA concentration                                                                          MEF cells devoid p23.
   FIG. 6. Sba1p reduces binding affinity Hsp90 GA. graph
displays change fluorescence anisotropy fluorescein-la-                               DISCUSSION
beled GA (FITC-GA) undergoes binds Hsp82p. data
points (averages replicates) fitted curves indicate         revisited phenotype S. cerevisiae cells lacking
changes absence presence fixed wild-type
                                                                         SBA1 gene discovered display increased
(WT) representative mutant Sba1p proteins. Kds calculated fitted curves shown legend. Curves addi-     sensitivity Hsp90 inhibitors. Using phenotype, tional mutants omitted clarity. Kds A13S, R106A,      determined known Sba1p activities important L107S 60.8 â«¾ 6.3, 51.1 â«¾ 6.7, 23.6 â«¾ 4.0 nM, respectively.   complementation. Hsp90 binding inhibition                                                                          ATPase activity required, intrinsic Sba1p
                                                                         chaperone function dispensable conferring relative resis-
inhibitor binding Hsp90. effect various Sba1p                tance Hsp90 inhibitors. results particular
derivatives binding affinity Hsp82p fluorescein-         Sba1p point mutant, Y116A, indicate abilities bind
labeled version GA (FITC-GA) determined                 inhibit ATPase sufficient protection using fluorescence anisotropy (Fig. 6). Strikingly, wild-type            inhibition ATPase protection Hsp90 inhib-
Sba1p complementing mutants A13S, R106A,                     itors distinct activities p23/Sba1p.  K113A impair GA binding twofold                   exception intrinsic chaperone activity Sba1p, complementation-defective mutants L107S Y116A barely                 assessed biochemical activities necessary protect cells. effect                                                   protective mutants qualitatively retain activi-
   Intriguingly, despite fact Y116A able bind             ties, quantitative differences inter-
Hsp90 high affinity, Y116A fails protect Hsp90           esting follow  Alterations components GA vitro radicicol vivo, interaction Hsp90        Hsp90 complex, notably Hsp90 itself, Sti1, Cpr7m, Cdc37, insensitive radicicol. Y116A readily coimmunopre-           previously reported render cells sensitive cipitated Hsp90 crude yeast extracts supplemented ATP,  unlike wild-type Sba1p, retains Hsp90 addition radicicol (Fig. 7) GA various GA
derivatives (data shown). biochemical experi-
ments suggest unusual mutant, able inhibit Hsp90 ATPase, prevent inhibitors binding possibly binds presence inhibitors. mutant, L107S, retains ability bind Hsp90 does complement, shares additional
biochemical characteristics Y116A remains analyzed.
   prediction experiments Hsp90
substrates vulnerable GA-induced degrada-
tion absence p23/Sba1p. experiments               FIG. 8. p23 protects Hsp90 substrate Raf-1 GA 
                                                                         duced degradation. Shown representative immunoblot extracts
difficult perform large-scale effects GA            wild-type (WT) p23-null MEFs treated 60 nM GA treatment cell growth survival, decided try              indicated times. Raf-1 levels standardized GAPDH, illustrate point examining model substrate.         starting level set 100   numbers micrograph).
 VOL. 28, 2008                                                                  p23 PROTECTS Hsp90 INHIBITORS                 3453


Hsp90 inhibitors (3, 12, 48, 49, 57). contrast cases,      findings yeast mammalian cells, influence hypersensitivity cells lacking Sba1p/p23        p23 levels GA sensitivity normal cancer merely synthetic effect attributed        cells interesting reexamine. Intriguingly, cancer loss direct protective effect cochaperone binding.      cells, particular metastatic cells, reported    p23/Sba1p protects cells Hsp90 inhibitors. S. cerevi-       higher levels p23 (29, 37), overexpression p23 siae âŒ¬sba1 strains established appear fully           MCF7 breast cancer cells stimulates ability invade viable. loss SBA1 compromises mainte-              fibronectin membrane (41). tempting speculate nance telomeres (59) lead genomic instability            cancer cells regulate p23 cope increased
(39) defective response amino acid starvation (14),           demand handling Hsp90 substrates protect possibly strain-specific fashion, cells eventually        Achilles heels, Hsp90, inhibitors pro-
adapt life Sba1p grow wild-type cells        duced metabolism taken food. conceiv-
(4, 15) (Fig. 1). fission yeast Schizosaccharomyces pombe,      able p23 functions including protective SBA1 ortholog WOS2 required thermotolerance (38),           posttranslationally regulated influenced nature indication case S. cerevisiae.   cochaperones substrate Hsp90
previous survey factors influence sensitivity     complex. phenotype Y116A mutant indication
Hsp90 inhibitors missed Sba1p (48), likely            subtle changes kind able affect âŒ¬sba1 strain deleted PDR5. Similarly,         ability wild-type p23 protect Hsp90. context large-scale chemical genetic screens Hsp90 inhibitors,        cancer therapy, predict tumor cells missed âŒ¬sba1 (64), did score âŒ¬sba1 hit,         rendered sensitive GA anticancer drug did highlight discuss finding (43). Al-        p23-targeted drugs small interfering RNA. observed hypersensitivity different            increased growth inhibition induction cell
strain backgrounds (data shown), exclude            death response Hsp90 inhibitors strain-specific penetrance trait. deletion      Hsp90 substrates fail. Bohen originally  gene encoding export pump Pdr5p clearly sensitized          ported deletion SBA1 gene renders mam- strains Hsp90 inhibitors facilitated display         malian glucocorticoid receptor assayed yeast strain
differential sensitivities (Fig. 1). Remarkably,         hypersensitive Hsp90 inhibitor, absence
p23 plays similar protective role MEFs, suggesting      Sba1p impact accumulation exogenous conserved function p23 regulatory               substrate (4). later confirmed observation p23-
functions Hsp90 cochaperone.                                     null MEFs (22). Despite functionally defective, levels
   Possible mechanism function protection. contrast          glucocorticoid receptor similar molecular chaperone function Sba1p, ability           p23-null wild-type cells.  suspect loss Sba1p bind Hsp90 inhibit ATPase              functionality Hsp90 substrates absence p23/
crucial, albeit sufficient, protecting cells Hsp90     Sba1p GA-induced degradation mechanisti-
inhibitors. biochemical correlate phenomenon            cally distinct events.  analysis Raf-1 sug-
likely equilibrium Sba1p-Hsp90 complex           gests Hsp90 substrates indirectly protected favored ATP binding Hsp90 inhibitor-             Hsp90 inhibitor-induced degradation protective
bound Hsp90 unable bind Sba1p (24, 26, 50, 60).        effect p23/Sba1p Hsp90.
suggests binding Sba1p Hsp90-ATP complex               Sba1p structure function. findings reveal Sba1p protect Hsp90 binding inhibitor molecule,          biochemical functions protein surfaces required compatible tight intimate nature ternary        vivo complementation. time complex (2) ability human p23 stabilize              extensive mutagenesis analysis performed. rea-
nucleotide-bound state Hsp90 (58). importantly,             son focusing mutagenesis separate regions demonstrated Sba1p directly reduces affinity          shown Fig. 9C residues lie Hsp90 GA.  Sba1p reduces affinity Hsp90         patch surface free p23 (60) (Fig. 9A). 
inhibitors pushes equilibrium ATP-bound              previous publications pinpointed resi-
form, explain Sba1p exert effect despite         dues right patch important Hsp90 10-fold abundant Hsp90. case           binding: I117 Sba1p (40) equivalent F121 yeast, interesting speculate protective function    W124 human p23 (63). Sba1p importance natural environment                  published crystal structures free form Hsp90 inhibitors radicicol GA produced           human p23 (60) Hsp90-bound Sba1p (2) largely microorganisms. evidence             identical overall fold, significant differences type pharmacological interaction species. rhizo-          details reinterpretation currently available
sphere fungus shown produce large amounts               structural information (Fig. 9). modeled Sba1p
Hsp90 inhibitors influence Hsp90 stress            polypeptide sequence human p23 structure com-
sponse higher plants associated fungus (34).              pare free bound forms. comparison    apparent contradiction findings yeast,     structures suggests Sba1p undergoes structural rear- suggested cancer cells higher affinity GA         rangements binding Hsp90, presumably favor Hsp90 complexes extensively associ-             stabilize tight packing apparent complex. ated cochaperones p23 (27).  view            particularly pronounced N-terminal portion beginning recently questioned (21),   light        W12. free form, residues 12 15  red Fig. 9)
 3454     FORAFONOV ET AL.                                                                                                      MOL. CELL. BIOL.




   FIG. 9. Model structural rearrangements Sba1p induced Hsp90 binding.   Model crystal structure N-terminal
domain Sba1p (residues 12 121). model Sba1p sequence known structure unbound human p23 (60), generated multiple-sequence alignment submitted fully automated protein structure homology-modeling server SWISS-MODEL (55). Residues
1 11 omitted resolved published structure Sba1p-Hsp82p complex (2). (B) Experimental crystal structure Sba1p complex Hsp82p (2). Rendering Sba1p structure PDB file 2CG9 PyMOL molecular graphics (W. L. DeLano, 2002; http://www.pymol.org). (C) Sequence alignment mutagenized sequence motifs. Colors red, purple, blue used residues conserved, green gray similar ones, respectively. (D) Surface
representations structures shown panels B. Black portions model unbound Sba1p correspond loops resolved published structure complex.



pack surface vicinity N-terminal         bind Hsp90, rationalized differently. conceivable signature motif WPRLTKE, remainder looping                    N-terminal portion mutant properly  binding Hsp90, residues â€œpulled ?               tethered core protein residue 12,  interior structure A13 R15 come lie far           mally close proximity hydrophobic L107, away W104 form large interface,               unable undergo large structural rearrangement K113 Y116, packs lid Hsp90.              binding Hsp90. Despite somewhat loosened structure, loop comes lie inside structure contrib-            W12A W104A retain chaperone activity. utes small â?¤-sheet.                                                      activity depends C-terminal domain Sba1,    structures interesting consider interpreting          known domain sufficient chaperone activity defects point mutants W12A W104A.                       extent N-terminal domain contributes. aromatic chains tryptophan resi-                  Surprisingly, Sba1p mutations map known
dues close proximity free form, far                Sba1p-Hsp90 interface effect minor
apart Sba1p binds Hsp90. Sba1p-Hsp90 complex,                  effect Hsp90 binding. A13, Q14, R15, K113, Y116 W12 constitutes N terminus defined structure,              localized large interface packs lid protrudes away core, involved pro-              Hsp90 consists Sba1p residues 13 16 113 118
tein-protein contacts. fact bulky chain               (2), A13S K113A slightly reduced Hsp90
W104 points inwards account increased protease               binding vitro IP experiments performed sensitivity observed mutant W104A. behavior                certain conditions. Single point mutants unable W12A mutant, similarly loosened unable                 weaken interaction sufficiently large size  VOL. 28, 2008                                                                                    p23 PROTECTS Hsp90 INHIBITORS                              3455

 particular interface. specific characteristics                              inducible kinase â?£ subunit eukaryotic translation initiation factor
                                                                                            kinase Gcn2. Mol. Cell. Biol. 19:8422â€“8432.
amino acid substitution mutant I117N explain                         15.   Fang, Y.,  E. Fliss, J. Rao,  J. Caplan. 1998. SBA1 encodes yeast
severely defective Hsp90 binding (40). Y116                              Hsp90 cochaperone homologous vertebrate p23 proteins. Mol.
interface, aromatic chain faces away Hsp90.                               Cell. Biol. 18:3727â€“3734.
                                                                                      16.   Felts, S. J., D. O. Toft. 2003. p23, simple protein complex explain Y116A mutant binds                                     activities. Cell Stress Chaperones 8:108â€“113.
Hsp90, unusual binding characteristics presence                         17.   Freeman, B. C., S. J. Felts, D. O. Toft, K. R. Yamamoto. 2000. p23
Hsp90 inhibitors understood detailed                                molecular chaperones act late step intracellular receptor action                                                                                             differentially affect ligand efficacies. Genes Dev. 14:422â€“434.
structural information.                                                               18.   Freeman, B. C., M. P. Myers, R. Schumacher, R.  Morimoto. 1995.
   Interestingly, residues interface abso-                           Identification regulatory motif Hsp70 affects ATPase activity,
                                                                                            substrate binding interaction HDJ-1. EMBO J. 14:2281â€“2292.
lutely conserved (Fig. 9C) (data shown). yeast                          19.   Freeman, B. C., D. O. Toft, R.  Morimoto. 1996. Molecular chaperone
Sba1p mutant A13S partially defective Hsp90 binding,                               machines: chaperone activities cylophilin Cyp-40 steroid
serine natural residue Drosophila melanogaster.                               aporeceptor-associated protein p23. Science 274:1718â€“1720.
                                                                                      20.   Freeman, B. C., K. R. Yamamoto. 2002. Disassembly transcriptional
human p23 mutant K95A, equivalent Sba1p                                     regulatory complexes molecular chaperones. Science 296:2232â€“2235.
mutant K113A, completely defective Hsp90 binding (47).                         21.   Gooljarsingh, L. T., C. Fernandes, K. Yan, H. Zhang, M. Grooms, K.  Sba1p bind yeast mammalian Hsp90,                                    Johanson, R. H. Sinnamon, R. B. Kirkpatrick, J. Kerrigan, T. Lewis, M.
                                                                                            Arnone,  J. King,  Lai, R.  Copeland, P. J. Tummino. 2006. yeast Hsp90 bind mammalian p23 (53). sug-                                   biochemical rationale anticancer effects Hsp90 inhibitors: slow,
gests large interface coordinate evolution                            tight binding inhibition geldanamycin analogues. Proc. Natl. Acad. contribute ensuring sufficient affinity protein-                             Sci. USA 103:7625â€“7630.
                                                                                      22.   Grad, , T.  McKee, S. M. Ludwig, G. W. Hoyle, P. Ruiz, W. Wurst, T.
protein interaction functionality molecular chap-                              Floss, C.  Miller III, D. Picard. 2006. Hsp90 cochaperone p23 erone complex.                                                                              essential perinatal survival. Mol. Cell. Biol. 26:8976â€“8983.
                                                                                      23.   Grad, , D. Picard. 2007. glucocorticoid responses shaped                                                                                             molecular chaperones. Mol. Cell. Endocrinol. 275:2â€“12.
                          ACKNOWLEDGMENTS                                             24.   Johnson, J., R. Corbisier, B. Stensgard, D. O. Toft. 1996. involve-
                                                                                            ment p23, hsp90, immunophilins assembly progesterone
   grateful Natasha Kralli Keith Yamamoto                            receptor complexes. J. Steroid Biochem. Mol. Biol. 56:31â€“37.
yeast strains. thank Marc Fischer Olivier DonzeÂ´                25.   Johnson, J. L.,  Halas, G. Flom. 2007. Nucleotide-dependent interac-
efforts early project Martin Hessling preliminary                        tion Saccharomyces cerevisiae Hsp90 cochaperone proteins Sti1,
biochemical experiments mutant. thank anonymous                              Cpr6, Sba1. Mol. Cell. Biol. 27:768â€“776.
reviewer thorough editing manuscript.                                      26.   Johnson, J. L., D. O. Toft. 1995. Binding p23 hsp90    Freeman lab University Illinois supported                         assembly progesterone receptor. Mol. Endocrinol. 9:670â€“678.
grant National Institutes Health (DK074270). Support                  27.   Kamal, , L. Thao, J. Sensintaffar, L. Zhang, M. F. Boehm, L. C. Fritz,                                                                                             F. J. Burrows. 2003. high-affinity conformation Hsp90 confers tumour Picard lab University came Canton Gene`ve,                                                                                             selectivity Hsp90 inhibitors. Nature 425:407â€“410.
Swiss National Science Foundation, Fondation Medic.                           28.   Knoblauch, R., M. J. Garabedian. 1999. Role Hsp90-associated
                                                                                            cochaperone p23 estrogen receptor signal transduction. Mol. Cell. Biol.
                                 REFERENCES                                                 19:3748â€“3759.
 1. Abbas-Terki, T., O. DonzeÂ´, P.  Briand, D. Picard. 2001. Hsp104             29.   Krebs, J., P. Saremaslani, R. Caduff. 2002. ALG-2: Ca2â«¹-binding
    interacts Hsp90 cochaperones respiring yeast. Mol. Cell. Biol. 21:              modulator protein involved cell proliferation cell death. Biochim.
    7569â€“7575.                                                                              Biophys. Acta 1600:68â€“73.
 2. Ali, M. M., S. M. Roe, C. K. Vaughan, P. Meyer, B. Panaretou, P. W. Piper,        30.   Louvion, J.-F., R. Warth, D. Picard. 1996. eukaryote-specific 
    C. Prodromou, L. H. Pearl. 2006. Crystal structure Hsp90-nucle-               gions Hsp82 dispensable viability signal transduction func-
    otide-p23/Sba1 closed chaperone complex. Nature 440:1013â€“1017.                          tions yeast. Proc. Natl. Acad. Sci. USA 93:13937â€“13942.
 3. Bandhakavi, S., R. O. McCann, D. E. Hanna, C. V. Glover. 2003.              31.   Lovgren,  K., M. Kovarova, B. H. Koller. 2007. cPGES/p23 required
    positive feedback loop protein kinase CKII Cdc37 promotes               glucocorticoid receptor function embryonic growth prosta-
    activity multiple protein kinases. J. Biol. Chem. 278:2829â€“2836.                     glandin E2 synthesis. Mol. Cell. Biol. 27:4416â€“4430.
 4. Bohen, S. P. 1998. Genetic biochemical analysis p23 ansamycin          32.   McLaughlin, S. H., H. W. Smith, S. E. Jackson. 2002. Stimulation     antibiotics function Hsp90-dependent signaling proteins. Mol. Cell.           weak ATPase activity human Hsp90 client protein. J. Mol. Biol.
    Biol. 18:3330â€“3339.                                                                     315:787â€“798.
 5. Bose, S., T. Weikl, H. Bu Â¨gl, J. Buchner. 1996. Chaperone function        33.   McLaughlin, S. H., F. Sobott,  P. Yao, W. Zhang, P. R. Nielsen, J. G.
    Hsp90-associated proteins. Science 274:1715â€“1717.                                       Grossmann, E. D. Laue, C. V. Robinson, S. E. Jackson. 2006.  6. Brachmann, C. B.,  Davies, G. J. Cost, E. Caputo, J. Li, P. Hieter, J. D.         chaperone p23 arrests Hsp90 ATPase cycle trap client proteins. J.
    Boeke. 1998. Designer deletion strains derived Saccharomyces cerevi-               Mol. Biol. 356:746â€“758.
    siae S288C: useful set strains plasmids PCR-mediated gene            34.   McLellan, C. , T. J. Turbyville, E. M. Wijeratne,  Kerschen, E. Vierling,
    disruption applications. Yeast 14:115â€“132.                                    C. Queitsch, L. Whitesell,   Gunatilaka. 2007. rhizosphere fungus
 7. Cox, M. B., C.  Miller III. 2002. p23 chaperone facilitates                enhances Arabidopsis thermotolerance production HSP90
    dioxin receptor signaling yeast model  Toxicol. Lett. 129:13â€“21.            inhibitor. Plant Physiol. 145:174â€“182.
 8. Cox, M. B., C.  Miller III. 2003. Pharmacological genetic analysis      35.   Mitsiades, C. S., N. S. Mitsiades, C. J. McMullan, V. Poulaki,  L. Kung,
    90-kDa heat shock isoprotein-aryl hydrocarbon receptor complexes. Mol.               F. E. Davies, G. Morgan, M. Akiyama, R. Shringarpure, N. C. Munshi, P. G.
    Pharmacol. 64:1549â€“1556.                                                                Richardson, T. Hideshima, D. Chauhan, X. Gu, C. Bailey, M. Joseph, T. 
 9. Cox, M. B., C.  Miller III. 2004. Cooperation heat shock protein 90            Libermann, N. S. Rosen, K. C. Anderson. 2006. Antimyeloma activity     p23 aryl hydrocarbon receptor signaling. Cell Stress Chaperones                  heat shock protein-90 inhibition. Blood 107:1092â€“1100.
    9:4â€“20.                                                                           36.   Mollerup, J., M. W. Berchtold. 2005. chaperone p23 degraded
10. Cullinan, S. B., L. Whitesell. 2006. Heat shock protein 90: unique                caspases proteasome apoptosis. FEBS Lett. 579:4187â€“
    chemotherapeutic target. Semin. Oncol. 33:457â€“465.                                      4192.
11. Dittmar, K. D., D. R. Demady, L. F. Stancato, P. Krishna, W. B. Pratt.        37.   Mollerup, J., T. N. Krogh, P. F. Nielsen, M. W. Berchtold. 2003. Prop-
    1997. Folding glucocorticoid receptor heat shock protein (hsp)            erties chaperone protein p23 erroneously attributed ALG-2
    90-based chaperone machinery. J. Biol. Chem. 272:21213â€“21220.                           (apoptosis-linked gene 2). FEBS Lett. 555:478â€“482.
12. Dolinski, K. J., M. E. Cardenas, J. Heitman. 1998. CNS1 encodes            38.   Mun Ëœ oz, M. J., E. R. Bejarano, R. R. Daga, J. Jimenez. 1999.     essential p60/Sti1 homolog Saccharomyces cerevisiae suppresses cy-              identification Wos2, p23 homologue interacts Wee1 Cdc2
    clophilin 40 mutations interacts Hsp90. Mol. Cell. Biol. 18:7344â€“              mitotic control fission yeasts. Genetics 153:1561â€“1572.
    7352.                                                                             39.   Ouspenski,  , S. J. Elledge, B. R. Brinkley. 1999. New yeast genes
13. DonzeÂ´, O., T. Abbas-Terki, D. Picard. 2001. Hsp90 chaperone                    important chromosome integrity segregation identified dosage
    complex facilitator repressor dsRNA-dependent kinase             effects genome stability. Nucleic Acids Res. 27:3001â€“3008.
    PKR. EMBO J. 20:3771â€“3780.                                                        40.   Oxelmark, E., R. Knoblauch, S. Arnal, L. F. Su, M. Schapira, M. J.
14. DonzeÂ´, O., D. Picard. 1999. Hsp90 binds regulates Gcn2, ligand-            Garabedian. 2003. Genetic dissection p23, Hsp90 cochaperone, reveals
 3456         FORAFONOV ET AL.                                                                                                                       MOL. CELL. BIOL.

      distinct surface involved estrogen receptor signaling. J. Biol. Chem.       52. Richter, K., S. Walter, J. Buchner. 2004. chaperone Sba1 
      278:36547â€“36555.                                                                     nects ATPase reaction Hsp90 progression chaperone
41.   Oxelmark, E., J. M. Roth, P. C. Brooks, S. E. Braunstein, R. J. Schneider,           cycle. J. Mol. Biol. 342:1403â€“1413.
      M. J. Garabedian. 2006. cochaperone p23 differentially regulates         53. Scheibel, T., T. Weikl, R. Rimerman, D. Smith, S. Lindquist, J. Buchner.
      estrogen receptor target genes promotes tumor cell adhesion inva-            1999. Contribution N- C-terminal domains function Hsp90
      sion. Mol. Cell. Biol. 26:5205â€“5213.                                                 Saccharomyces cerevisiae. Mol. Microbiol. 34:701â€“713.
42.   Panaretou, B., C. Prodromou, S. M. Roe, R. Oâ€™Brien, J. E. Ladbury, P. W.         54. Schulte, T. W., M. V. Blagosklonny, C. Ingui, L. Neckers. 1995. Disrup-
      Piper, L. H. Pearl. 1998. ATP binding hydrolysis essential        tion Raf-1-Hsp90 molecular complex results destabilization       function Hsp90 molecular chaperone vivo. EMBO J. 17:4829â€“4836.             Raf-1 loss Raf-1-Ras association. J. Biol. Chem. 270:24585â€“24588.
43.   Parsons,  B.,  Lopez,  E. Givoni, D. E. Williams, C.  Gray, J. Porter,   55. Schwede, T., J. Kopp, N. Guex, M. C. Peitsch. 2003. SWISS-MODEL:       G. Chua, R. Sopko, R. L. Brost, C. H. Ho, J. Wang, T. Ketela, C. Brenner,            automated protein homology-modeling server. Nucleic Acids Res. 31:3381â€“
      J.  Brill, G. E. Fernandez, T. C. Lorenz, G. S. Payne, S. Ishihara, Y. Ohya,       3385.
      B. Andrews, T. R. Hughes, B. J. Frey, T. R. Graham, R. J. Andersen, C.       56. Siligardi, G., B. Hu, B. Panaretou, P. W. Piper, L. H. Pearl, C. Prodromou.
      Boone. 2006. Exploring mode action bioactive compounds chem-            2004. chaperone regulation conformational switching Hsp90
      ical-genetic profiling yeast. Cell 126:611â€“625.         